Abingworth
About Abingworth
Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs.
Investment focus
Stages
Sectors
Portfolio (3 in our database)
Tizona TherapeuticsTizona develops next-generation immunotherapiesCorporate Round · $370M raisedWugenWugen is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignanciesSeries B · $172M raisedQ32 BioQ32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.Series B · $106M raised